HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$1.30
Day range
$1.28 - $1.34
Year range
$1.04 - $2.68
Market cap
202.35M USD
Avg Volume
1.87M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 37.20M | 3.26% |
Operating expense | 26.05M | -5.35% |
Net income | -2.38M | 74.22% |
Net profit margin | -6.40 | 75.04% |
Earnings per share | -0.02 | 66.67% |
EBITDA | -1.03M | 82.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.63M | -39.67% |
Total assets | 232.09M | 6.40% |
Total liabilities | 259.35M | 1.28% |
Total equity | -27.26M | — |
Shares outstanding | 153.29M | — |
Price to book | -7.22 | — |
Return on assets | -1.75% | — |
Return on capital | -2.74% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.38M | 74.22% |
Cash from operations | -10.87M | -136.06% |
Cash from investing | 7.33M | 258.11% |
Cash from financing | 781.00K | 58.74% |
Net change in cash | -2.75M | -33.38% |
Free cash flow | -11.09M | -133.75% |
About
Founded
1983
Headquarters
Website
Employees
122
